WHWK

Whitehawk Therapeutics Inc

• TipRanks·10/01 12:15

  Whitehawk Therapeutics presents real-world analyses of MUC16 in ovarian cancer

• Benzinga·10/01 12:05

  Whitehawk Therapeutics Presents Two-Real World Analyses Supporting Mucin 16

• Dow Jones·10/01 11:13

  Whitehawk Therapeutics Price Target Announced at $9.00/Share by Stifel

• Dow Jones·10/01 11:13

  Whitehawk Therapeutics Initiated at Buy by Stifel

• Benzinga·10/01 11:03

  Stifel Initiates Coverage On Whitehawk Therapeutics with Buy Rating, Announces Price Target of $9

• TipRanks·09/30 20:15

  Whitehawk Therapeutics initiated with a Buy at Stifel

• NASDAQ·09/14 15:07

  Whitehawk Therapeutics: PTK7 Stability Supports ADC Development In EGFR Wild-Type NSCLC

• TipRanks·09/14 13:30

  Analysts’ Top Healthcare Picks: Scholar Rock Holding (SRRK), Whitehawk Therapeutics (WHWK)

• TipRanks·09/14 09:40

  Whitehawk Therapeutics presents PTK7 data at WCLC 2026

• Benzinga·09/14 05:36

  Reported Sunday, Whitehawk's Real-World Data Show PTK7 Expression Remains Stable After Standard-Of-Care Therapies, Reinforcing Rationale For HWK-007 In EGFR Wild-Type NSCLC

• TipRanks·09/10 21:29

  Whitehawk Therapeutics Adds Oncology Leader to Board

• Dow Jones·09/10 20:11

  *Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Bd of Directors

• Dow Jones·09/10 20:05

  Press Release: Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

• TipRanks·08/07 07:56

  TD Cowen Remains a Hold on Whitehawk Therapeutics (WHWK)

• TipRanks·08/07 01:30

  Wall Street Analysts Are Bullish on Top Healthcare Picks